Prestige Wealth Management Group LLC Sarepta Therapeutics, Inc. Transaction History

Prestige Wealth Management Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2024	BUY	$117.53 - $155.99 $1,998 - $2,651	17 New	17 $2,000
Q1 2023 May 16, 2023	BUY	$117.53 - $155.99 $822 - $1,091	7 Added 70.0%	17 $2,000
Q2 2022 Aug 10, 2022	SELL	$62.69 - $88.44 $1,629 - $2,299	-26 Reduced 72.22%	10 $1,000
Q4 2021 Feb 15, 2022	BUY	$77.28 - $99.42 $77 - $99	1 Added 2.86%	36 $3,000
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $1,011 - $2,365	14 Added 66.67%	35 $3,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $372 - $686	-4 Reduced 16.0%	21 $3,000
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $2,059 - $3,290	25 New	25 $2,000

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.